Dupont Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,202
Closed -$41K 1641
2022
Q2
$41K Sell
1,202
-193
-14% -$6.76K ﹤0.01% 1295
2022
Q1
$49K Buy
1,395
+676
+94% +$23.1K ﹤0.01% 1340
2021
Q4
$22K Sell
719
-556
-44% -$18.1K ﹤0.01% 1516
2021
Q3
$42K Sell
1,275
-10,207
-89% -$327K ﹤0.01% 1454
2021
Q2
$347K Buy
+11,482
New +$378K 0.01% 1154

Other funds holding OGN

Dupont Capital Management's OGN Position: Q3 2022 in Review

Dupont Capital Management sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 1,202 shares — an estimated $41K sold.

Dupont Capital Management first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $347K in Q2 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Dupont Capital Management reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Dupont Capital Management sold 1,202 Organon & Co shares in Q3 2022, an estimated $41K.
  • Dupont Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Dupont Capital Management's Organon & Co position peaked at $347K in Q2 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Dupont Capital Management's 13F filing for Q3 2022, filed 31 Oct 2022.